PROTALIX BIOTHERAPEUTICS, INC. (PLX)

[Spideyboy]

Having I feel, become quite familiar with the situation to date, this really didn't take up too much of my time at all, and it allowed me to check up Amicus's recent developments which was advantageous too. But thanks and of course you're welcome.

Indeed, Chiesi earmarking a total of about 1 billion to PRX-102 is a good sign from a good company.

Earlier I was hoping we might see 6 month interim Bright data like we did for Bridge, but as of the last earnings call PLX mentioned that they will be reporting 1 year interim Bright data, based on the different trial design (for longer term efficacy), which I agree with them on. So expecting to see this towards mid-end 2019. At the moment eyes are on FDA Type-C meeting which should be for this quarter.